Inex regulatory update

IEX received U.S. Patent No. 5,543,152 covering applications of its transmembrane carrier system (TCS), which can deliver drugs to a range of disease sites. The claims include a TCS comprised of two lipids - sphingomyelin and cholesterol. In preclinical studies, the system has provided extended circulation time, increased drug retention and greater stability, IEX said. ...